+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Tumor Treating Fields Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6242771
UP TO OFF until Jan 01st 2027
The Tumor Treating Fields Market is estimated at US$483.8 million in 2026 and is projected to grow at a CAGR of 16.6% to reach US$1.65 billion by 2034.

Market Overview

The Tumor Treating Fields Market covers medical technology systems that use alternating electric fields to disrupt cancer cell division and support treatment of selected solid tumors. Its value chain includes device manufacturers, oncology centers, hospitals, specialty distributors, patient support teams, payers, and treating clinicians.

Core applications include brain tumor management, supportive oncology care, long term outpatient treatment, combination treatment pathways, and specialist cancer center protocols. Demand reflects the need for novel cancer treatment options, specialist interest in non drug adjunctive therapies, precision oncology expansion, and demand for improved outcomes in difficult tumor.

Key Companies Analysed

  • Novocure
  • Medtronic
  • Johnson & Johnson MedTech
  • Stryker
  • Zimmer Biomet
  • Boston Scientific
  • Abbott
  • Baxter
  • GE HealthCare
  • Siemens Healthineers
  • Philips
  • Roche
  • Merck & Co
  • Bristol Myers Squibb
  • AstraZeneca
  • Novartis
  • Amgen
  • Eli Lilly
  • Pfizer
  • AbbVie

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Tumor Treating Fields Market Overview
2.1. Tumor Treating Fields Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Tumor Treating Fields Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Tumor Treating Fields Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Tumor Treating Fields Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ million)
6. North America Tumor Treating Fields Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
7. Europe Tumor Treating Fields Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia
8. Asia-Pacific Tumor Treating Fields Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam
9. Middle East and Africa Tumor Treating Fields Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt
10. South and Central America Tumor Treating Fields Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru
11. Tumor Treating Fields Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Novocure
11.2.2. Medtronic
11.2.3. Johnson & Johnson MedTech
11.2.4. Stryker
11.2.5. Zimmer Biomet
11.2.6. Boston Scientific
11.2.7. Abbott
11.2.8. Baxter
11.2.9. GE HealthCare
11.2.10. Siemens Healthineers
11.2.11. Philips
11.2.12. Roche
11.2.13. Merck & Co
11.2.14. Bristol Myers Squibb
11.2.15. AstraZeneca
11.2.16. Novartis
11.2.17. Amgen
11.2.18. Eli Lilly
11.2.19. Pfizer
11.2.20. AbbVie
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Novocure
  • Medtronic
  • Johnson & Johnson MedTech
  • Stryker
  • Zimmer Biomet
  • Boston Scientific
  • Abbott
  • Baxter
  • GE HealthCare
  • Siemens Healthineers
  • Philips
  • Roche
  • Merck & Co
  • Bristol Myers Squibb
  • AstraZeneca
  • Novartis
  • Amgen
  • Eli Lilly
  • Pfizer
  • AbbVie

Table Information